Clinical Trial Update: CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the maximum tolerated dose of Campto (irinotecan) when given with cisplatin and radiotherapy for advanced cervical cancer to establ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Campto (irinotecan)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Cervix Cancer | Phase 1 | Status: COMPLETED